Come up with a name for your new list and we'll add to it:
Tethys Bioscience raised a round of funding on October 11, 2005. Investors include
Mohr Davidow Ventures.
Tethys Bioscience is engaged in efforts to create and commercialize blood tests that accurately assess imminent disease risk with an aim of helping physicians preempt the onset of chronic cardiometabo…